Margaret M Fitzpatrick
Director at AN2 Therapeutics, Inc. (ANTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$2K
Total bought / sold$12K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 2SEC | ANTXAN2 Therapeutics, Inc. | Buy | 2,09810,708 held (+24%) | $5.53 | $12K | -20.4% |
- Buy
Director Margaret M Fitzpatrick bought $12K of ANTX at $5.53 — first open-market purchase in our records; raises the stake by 24%.